The October 20, 2017, article by Shore et al entitled “Intravesical rAd–IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin–Refractory or Relapsed Non–Muscle-Invasive Bladder Cancer: A Phase II Randomized Study” (J Clin Oncol: 10.1200/JCO.2017.72.3064) was published with an error.
In the section Authors’ Disclosures of Potential Conflict of Interest, Colin P.N. Dinney’s disclosures were presented as “Other Relationship: FKD Therapies Oy, University of Michigan Comprehensive Center.”
They should have been presented as “Consulting or Advisory Role: FKD Therapies Oy, Research Funding: FKD Therapies Oy, Other Relationship: University of Michigan Comprehensive Center.”
This has been corrected as of July 19, 2019. Journal of Clinical Oncology apologizes for the error.